Eiko Lifesciences Limited has announced a board meeting to discuss the certificate under Regulation 74(5) of SEBI for the quarter and year ended 31st March 2025. Bigshare Services Pvt. Ltd., the company’s Registrar and Share Transfer Agent, confirmed that there were no requests for the dematerialization of equity shares during the specified period. This stability indicates a steady shareholder base, potentially enhancing investor confidence. Overall, the lack of dematerialization requests suggests a positive outlook for the company, underscoring its operational stability and shareholder engagement.